RxDoctor Payments Data

David Beckmann, MD

Family Medicine · Evergreen Park, ILNPI 1407015704

Payments from drug & device makers

$10,985in general payments, 2019–2025

Across 591 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • Novo Nordisk$1K
  • AbbVie$1K
  • GSK$1K
  • Lilly USA, LLC$1K
  • AstraZeneca$990
  • plus $4K from 44 others

What the payments were for

  • Food & beverage$10,977100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,985 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$193,479
Medicare patients
295
Services billed
4,150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$120,515
RybelsusSemaglutide51$106,361
FarxigaDapagliflozin Propanediol86$98,530
Trelegy ElliptaFluticasone/Umeclidin/Vilanter98$86,398
EliquisApixaban72$63,411
MounjaroTirzepatide37$58,649
JardianceEmpagliflozin58$56,829
TrulicityDulaglutide46$49,809
JanuviaSitagliptin Phosphate30$23,518
RexultiBrexpiprazole12$20,301
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$13,554
XareltoRivaroxaban11$13,424
Tresiba Flextouch U-100Insulin Degludec18$13,354
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog34$9,131
JanumetSitagliptin Phos/Metformin Hcl12$8,068

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,295$226,876140 claims
AstraZenecaFarxiga, Breztri Aerosphere$990$112,084107 claims
Lilly USA, LLCMounjaro, Trulicity$1,088$108,45883 claims
GSKTrelegy Ellipta, Shingrix$1,196$91,309120 claims
PfizerEliquis, Abrysvo$1,516$68,52988 claims
Boehringer IngelheimJardiance$206$56,82958 claims
MerckJanuvia, Janumet$44$31,58642 claims
Otsuka America Pharmaceutical, Inc.Rexulti$243$20,30112 claims
Johnson & JohnsonXarelto$133$13,42411 claims
Sanofi-aventis U.S. LLCLantus$159$2,62215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Evergreen Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →